Consistent with our observations in the cell lines and DSS-induced colon cancer animal model above, doxorubicin treatment caused MCL1 to translocate into the nucleus in p53WT and p53negative PDXs (Fig. 2G). This evidence concerns the gene MCL1 and malignant colon neoplasm.